A retrospective claims review published in JMCP found that switching or discontinuing biologics in patients with psoriasis resulted in higher health care utilization and overall medical costs.
A retrospective claims review published in JMCP found that switching or discontinuing biologics in patients with psoriasis resulted in higher health care utilization and overall medical costs.
Find out about Previous Versions to AMCP's Format for Formulary Submission
AMCP webinar that provided an overview of key updates to the Format, Version 4.0, including new guidance related to emerging special topic considerations such as biosimilars, specialty drugs, and companion diagnostic tests.
A Format for Submission of Clinical and Economic Evidence of Pharmaceuticals in Support of Formulary Consideration Developed by the AMCP Format Executive Committee Copyright © 2016 Academy of Managed Care Pharmacy
DRAFT for Public Comment AMCP Format for Formulary Submissions, Version 4.0
A Format for Submission of Clinical and Economic Evidence of Pharmaceuticals in Support of Formulary Consideration Copyright © 2002 Academy of Managed Care Pharmacy
A Format for Submission of Clinical and Economic Evidence of Pharmaceuticals in Support of Formulary Consideration Copyright © 2000 Academy of Managed Care Pharmacy
